Sort
23,748 grants matching “melanoma”
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$363,204Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · CA
Paradoxical roles of tumor lymphangiogenesis on tumor immunity and implications for immunotherapy - Resubmission 01
$363,164Melody A Swartz · University Of Chicago · R01 · FY2022 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$363,125Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$363,125Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$363,125Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$363,124Yuhang Zhang · University Of Cincinnati · R01 · FY2025 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$363,090Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Targeted therapies in cutaneous melanoma
$363,090Andrew E Aplin · Thomas Jefferson University · R01 · FY2023 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$363,090Roger S Lo · University Of California Los Angeles · R01 · FY2022 · CA
Targeted therapies in cutaneous melanoma
$363,090Andrew E Aplin · Thomas Jefferson University · R01 · FY2022 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$363,090Roger S Lo · University Of California Los Angeles · R01 · FY2023 · CA
Cancer prevention and treatment by activation of a brain-adipocyte axis
$363,090Lei Cao · Ohio State University · R01 · FY2022 · CA
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$363,077Dai Fukumura · Massachusetts General Hospital · R01 · FY2025 · NS
Regulation of cytosolic pattern recognition receptor signaling in macrophages
$363,075Christian Stehlik · Northwestern University At Chicago · R01 · FY2013 · AI
A NON INVASIVE DERMATOLOGICAL LESION CLASSIFIER
$363,073Western Research Company, Inc. · R44 · FY2000 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$363,051Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2014 · CA
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
$363,046Victor H. Engelhard · University Of Virginia · R01 · FY2011 · AI
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$362,913Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Regulation of interferon signaling in melanoma by the cohesin complex protein STAG2 via 3D genome organization
$362,913Bin Zheng · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Cellular Mechanisms of Therapy Resistance in Melanoma
$362,782Meenhard Herlyn · Wistar Institute · P01 · FY2012 · CA
Adhesive regulation during cell migration
$362,722Anna Huttenlocher · University Of Wisconsin-Madison · R01 · FY2025 · CA
Adhesive regulation during cell migration
$362,722Anna Huttenlocher · University Of Wisconsin-Madison · R01 · FY2022 · CA
Adhesive regulation during cell migration
$362,722Anna Huttenlocher · University Of Wisconsin-Madison · R01 · FY2023 · CA
MOLECULAR DETERMINANTS OF MELANOMA SUSCEPTIBILITY AND PROGRESSION
$362,700University Of Utah · · FY2010 · Department of Defense
Langerhans vs monocyte-derived dendritic cell vaccines
$362,675Sloan-Kettering Institute For Cancer Res · R21 · FY2003 · CA